1467P POLO: Long-term safety and tolerability of olaparib for patients with a germline BRCA mutation and metastatic pancreatic cancer

Autor:	Talia Golan, S. Bordia, Hedy L. Kindler, Giampaolo Tortora, Daniel Hochhauser, E. Van Cutsem, Pascal Hammel, Gershon Y. Locker, Hana Algül, T. Macarulla Mercade, Anke Reinacher-Schick, David McGuinness, D-Y. Oh, Karen Cui, Michele Reni, Dirk Arnold, Eileen M. O'Reilly, J.O. Park, Michael J. Hall
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry BRCA mutation Hematology Germline Olaparib chemistry.chemical_compound chemistry Tolerability Internal medicine Metastatic pancreatic cancer Medicine Long term safety business
Zdroj:	Annals of Oncology. 32:S1085-S1086
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.795
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b79d3c4dabed874ceb38f9c4a0004d46 https://doi.org/10.1016/j.annonc.2021.08.795 Zobrazit plný text záznamu